BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 17, 2008
View Archived Issues
Transition Could Get $130M in Diabetes Deal With Lilly
Transition Therapeutics Inc. could receive up to $137 million in a deal with drug giant Eli Lilly and Co., which will acquire rights to Transition's gastrin-based therapies for diabetes. (BioWorld Today)
Read More
Legislation Would Create Path for Follow-on Biologics Work
Read More
T-Cell Gene is Linchpin for Breast Cancer Metastasis
Read More
Investigations Looming in Off-Label Promotion
Read More
Corrections & Clarifications
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Appointments And Advancements
Read More